{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"FibroGen, Inc"},"Symbol":{"label":"Symbol","value":"FGEN"},"Address":{"label":"Address","value":"409 ILLINOIS STREET, SAN FRANCISCO, California, 94158, United States"},"Phone":{"label":"Phone","value":"+1 415 978-1200"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates."},"CompanyUrl":{"label":"Company Url","value":"https://www.fibrogen.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Elias Kouchakji","title":"Senior VP-Clinical Development & Drug Safety"},{"name":"John Hunter","title":"Chief Scientific Officer"},{"name":"Rahul Rajan Kaushik","title":"SVP-Technical Operations & Manufacturing"},{"name":"Thane Wettig","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}